Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfuzosin 10 mg in Patients with LUTS/BPH
NCT00637715Phase 4Completed
- Sponsor
- Sanofi
- Start
- Oct 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of alfuzosin in benign prostatic hyperplasia (BPH), sponsored by Sanofi. Started Oct 2003; status: completed.
02
Drugs
alfuzosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00637715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00637715.